Sensus Healthcare Inc expected to post earnings of 12 cents a share - Earnings Preview

Sensus Healthcare

03/02/2025 21:45

* Sensus Healthcare Inc  SRTS.OQ   SRTS.O  is expected
to show a
fall in quarterly revenue when it reports  results on February 5
for the period ending December 31 2024
    * The Boca Raton Florida-based  company is expected to
report a
13.7% decrease in revenue to $10.845 million from $12.57 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Sensus Healthcare Inc is
for
earnings of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sensus
Healthcare
Inc is $11.00​, above​ its last closing price of $8.24. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  0.00        -0.01      0.07      Beat    800
 Jun. 30 2024  0.02        0.02       0.10      Beat    328.6
 Mar. 31 2024  -0.06       -0.05      0.14      Beat    354.5​
 Dec. 31 2023  0.14        0.12       0.26      Beat    113.1
 ​​Sep.        -0.01       -0.02      -0.09     Missed  -400
 30 2023                                                
 Jun. 30 2023  -0.08       -0.08      -0.02     Beat    73.7​
 Mar. 31 2023  0.12        0.13       -0.12     Missed  -193.7
 Dec. 31 2022  0.25        0.23       0.17      Missed  -26.1
 This summary was machine generated February 3 at 21:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)